Eribulin Provides a Remarkable Effect in Trabectedin-Resistant Myxoid Liposarcoma

Adriamycin-based chemotherapy is commonly used for malignant soft tissue sarcoma including myxoid liposarcoma. However, in the case of unavailability or failure of the adriamycin-based regimen, trabectedin or eribulin can produce a good antitumor effect for myxoid liposarcoma. We relate the experien...

Full description

Bibliographic Details

Published in:	Case Reports in Orthopedics
Main Authors:	Hironari Tamiya, Hideaki Sabe, Katsunari Yamashita, Yoshinori Imura, Toru Wakamatsu, Satoshi Takenaka
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Online Access:	http://dx.doi.org/10.1155/2020/8873185